Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024 17:09 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, May 23, 2024 (GLOBE NEWSWIRE) -- Results will be presented at American Society of Clinical Oncology (ASCO) Annual MeetingMedian overall survival was 20.3 months, nearly doubling the...
Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024
May 23, 2024 10:00 ET
|
Syntekabio USA Inc.
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the BIO International Convention...
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
May 22, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 22, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) proudly announces the initiation of synergy and efficacy testing for two promising drug...
Pattern to Present at 2024 BIO International Convention
May 21, 2024 08:30 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 21, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will present at the upcoming 2024 BIO...
United States Toxicology Laboratories Industry Research Report 2024 Featuring Abbott Laboratories, Laboratory Corporation Of America, Quest Diagnostics, and Clinical Reference Laboratory
May 20, 2024 09:38 ET
|
Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Toxicology Laboratories in the US - Industry Market Research Report" report has been added to ResearchAndMarkets.com's offering.The Toxicology...